Seaport Therapeutics
SPTX19.9103.07% ( -0.630 )
Seaport Therapeutics (SPTX)
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and...
- Open
- 20.650
- High
- 20.650
- Low
- 19.625
- Prev. Close
- 20.540
- Volume
- 26.52K
- Turnover
- 534.78K
- Avg Price
- 20.166
- Bid/Ask Ratio
- --
- Amplitude
- 4.99%
- 52wk High
- 23.000
- Volume Ratio
- 0.51
- Turnover Ratio
- 0.09%
Seaport Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$38.0093.93%
Forecast & RatingBuy
6analysts
- Strong buy66.67%
- Buy16.67%
- Hold16.67%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jun 24 at 05:05 AM
Seaport Therapeutics director Robert J. Hombach trust buys 13,000 shares worth $235,768
- Tip Ranks · Jun 9 at 10:29 AM
3 Best Stocks to Buy Today, 6/9/2026, According to Top Analysts
- benzinga_article · Jun 9 at 09:55 AM
Seaport Therapeutics shares are trading higher after the company announced data from the multiple-ascending dose portion of its Phase 1 proof-of-concept clinical trial evaluating repeat dosing of GlyphAgo in healthy volunteers.
- Baystreet · Jun 8 at 09:15 AM
Seaport Pops on Q1 Numbers
- StockTitan · Jun 7 at 10:05 PM
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress | SPTX Stock News
- TradingView · May 11 at 06:56 PM
General Atlantic Discloses Investment at Seaport Therapeutics with 11.5% Stake
